Literature DB >> 24853593

Every Newborn: progress, priorities, and potential beyond survival.

Joy E Lawn1, Hannah Blencowe2, Shefali Oza2, Danzhen You3, Anne C C Lee4, Peter Waiswa5, Marek Lalli2, Zulfiqar Bhutta6, Aluisio J D Barros7, Parul Christian8, Colin Mathers9, Simon N Cousens2.   

Abstract

In this Series paper, we review trends since the 2005 Lancet Series on Neonatal Survival to inform acceleration of progress for newborn health post-2015. On the basis of multicountry analyses and multi-stakeholder consultations, we propose national targets for 2035 of no more than 10 stillbirths per 1000 total births, and no more than 10 neonatal deaths per 1000 livebirths, compatible with the under-5 mortality targets of no more than 20 per 1000 livebirths. We also give targets for 2030. Reduction of neonatal mortality has been slower than that for maternal and child (1-59 months) mortality, slowest in the highest burden countries, especially in Africa, and reduction is even slower for stillbirth rates. Birth is the time of highest risk, when more than 40% of maternal deaths (total about 290,000) and stillbirths or neonatal deaths (5·5 million) occur every year. These deaths happen rapidly, needing a rapid response by health-care workers. The 2·9 million annual neonatal deaths worldwide are attributable to three main causes: infections (0·6 million), intrapartum conditions (0·7 million), and preterm birth complications (1·0 million). Boys have a higher biological risk of neonatal death, but girls often have a higher social risk. Small size at birth--due to preterm birth or small-for-gestational-age (SGA), or both--is the biggest risk factor for more than 80% of neonatal deaths and increases risk of post-neonatal mortality, growth failure, and adult-onset non-communicable diseases. South Asia has the highest SGA rates and sub-Saharan Africa has the highest preterm birth rates. Babies who are term SGA low birthweight (10·4 million in these regions) are at risk of stunting and adult-onset metabolic conditions. 15 million preterm births, especially of those younger than 32 weeks' gestation, are at the highest risk of neonatal death, with ongoing post-neonatal mortality risk, and important risk of long-term neurodevelopmental impairment, stunting, and non-communicable conditions. 4 million neonates annually have other life-threatening or disabling conditions including intrapartum-related brain injury, severe bacterial infections, or pathological jaundice. Half of the world's newborn babies do not get a birth certificate, and most neonatal deaths and almost all stillbirths have no death certificate. To count deaths is crucial to change them. Failure to improve birth outcomes by 2035 will result in an estimated 116 million deaths, 99 million survivors with disability or lost development potential, and millions of adults at increased risk of non-communicable diseases after low birthweight. In the post-2015 era, improvements in child survival, development, and human capital depend on ensuring a healthy start for every newborn baby--the citizens and workforce of the future.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24853593     DOI: 10.1016/S0140-6736(14)60496-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  565 in total

1.  The development and implementation of a newborn medicine program in a resource-limited setting.

Authors:  A Hansen; H Magge; M Labrecque; R B M Munyaneza; E Nahimana; M Nyishime; A Mwali
Journal:  Public Health Action       Date:  2015-03-21

2.  Association of type of birth attendant and place of delivery on infant mortality in sub-Saharan Africa.

Authors:  Whitney A Stanley; Larissa R Brunner Huber; Sarah B Laditka; Elizabeth F Racine
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  Association of Temporal Changes in Gestational Age With Perinatal Mortality in the United States, 2007-2015.

Authors:  Cande V Ananth; Robert L Goldenberg; Alexander M Friedman; Anthony M Vintzileos
Journal:  JAMA Pediatr       Date:  2018-07-01       Impact factor: 16.193

4.  Special issue: newborn health in Uganda.

Authors:  Kate Kerber; Stefan Peterson; Peter Waiswa
Journal:  Glob Health Action       Date:  2015-03-31       Impact factor: 2.640

5.  Hydrogen inhalation protects hypoxic-ischemic brain damage by attenuating inflammation and apoptosis in neonatal rats.

Authors:  Guojiao Wu; Zhiheng Chen; Peipei Wang; Mingyi Zhao; Masayuki Fujino; Chen Zhang; Wenjuan Zhou; Shin-Ichi Hirano; Xiao-Kang Li; Lingling Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-12

6.  Automated quantitative evaluation of brain MRI may be more accurate for discriminating preterm born adults.

Authors:  Alina Jurcoane; Marcel Daamen; Vera C Keil; Lukas Scheef; Josef G Bäuml; Chun Meng; Afra M Wohlschläger; Christian Sorg; Barbara Busch; Nicole Baumann; Dieter Wolke; Peter Bartmann; Henning Boecker; Guido Lüchters; Milka Marinova; Elke Hattingen
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

7.  Variation in the Phototherapy Practices and Irradiance of Devices in a Major Metropolitan Area.

Authors:  Amy R Borden; Katie M Satrom; Paul Wratkowski; Thomas N George; Constance A Adkisson; Hendrik J Vreman; Austin P Johnson; Kent J Nichols; Tina M Slusher
Journal:  Neonatology       Date:  2018-01-31       Impact factor: 4.035

8.  Outcome of stoma closure in babies with necrotising enterocolitis: early vs late closure.

Authors:  Debasish Bijoykrishna Banerjee; Hasanthi Vithana; Shilpa Sharma; Thomas Tat Ming Tsang
Journal:  Pediatr Surg Int       Date:  2017-04-22       Impact factor: 1.827

9.  An mHealth monitoring system for traditional birth attendant-led antenatal risk assessment in rural Guatemala.

Authors:  Lisa Stroux; Boris Martinez; Enma Coyote Ixen; Nora King; Rachel Hall-Clifford; Peter Rohloff; Gari D Clifford
Journal:  J Med Eng Technol       Date:  2016-10-04

10.  Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.

Authors:  Shiyam S Tikmani; Amber A Muhammad; Yasir Shafiq; Saima Shah; Naresh Kumar; Imran Ahmed; Iqbal Azam; Omrana Pasha; Anita K M Zaidi
Journal:  Clin Infect Dis       Date:  2016-10-19       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.